Lymphoedema Diagnostics Market Size, Share, And Growth Report 2032

Lymphoedema Diagnostics Market by technology (X-ray Lymphography, Lymphoscintigraphy, Computed Tomography, Ultrasound Imaging, Magnetic Resonance Imaging, Bioimpedance Analysis, Near-infrared Fluorescence Imaging, ICG Lymphography and Fluorescein Sodium Microlymphangiography), by disease type (Cancer, Cardiovascular Disease, Inflammatory Diseases and Other Diseases), by end user (hospitals, diagnostic centers, research & academic institutes and other end users), By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032

Category: Healthcare Report Format : PDF Pages: 130 Report Code: ZMR-4982 Published Date: Aug-2024 Status : Published

Market Size in 2023	Market Forecast in 2032	CAGR (in %)	Base Year
USD 32.68 Million	USD 62.66 Million	7.5%	2023

Table Of Content

Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
  - 1.3.1. Market Research Process
  - 1.3.2. Market Research Methodology
Chapter 2. Executive Summary
- 2.1. Lymphoedema Diagnostics Market, 2016-2025 (USD Million)
- 2.2. Lymphoedema Diagnostics Market: Snapshot
Chapter 3. Lymphoedema Diagnostics Market - Industry Analysis
- 3.1. Lymphoedema Diagnostics Market: Market Dynamics
- 3.2. Market Drivers
  - 3.2.1. Driver 1
  - 3.2.2. Driver 2
- 3.3. Restraints
  - 3.3.1. Restraint 1
  - 3.3.2. Restraint 2
- 3.4. Opportunity
  - 3.4.1. Government funding and support
- 3.5. Porter's Five Forces Analysis
- 3.6. Market Attractiveness Analysis
  - 3.6.1. Market attractiveness analysis By Product
  - 3.6.2. Market attractiveness analysis By Disease type
  - 3.6.3. Market attractiveness analysis By Distribution Channel
  - 3.6.4. Market attractiveness analysis By Region
Chapter 4. Lymphoedema Diagnostics Market- Competitive Landscape
- 4.1. Company market share analysis
  - 4.1.1. Global Lymphoedema Diagnostics Market: company market share, 2018
- 4.2. Strategic development
  - 4.2.1. Acquisitions & mergers
  - 4.2.2. New Product launches
  - 4.2.3. Agreements, partnerships, collaborations and joint ventures
  - 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
Chapter 5. Global Lymphoedema Diagnostics Market - Technology Analysis
- 5.1. Global Lymphoedema Diagnostics Market overview: By Technology
  - 5.1.1. Global Lymphoedema Diagnostics Market share, By Product,2018 and 2025
- 5.2. X-ray Lymphography
  - 5.2.1. Global Lymphoedema Diagnostics Market By Product1, 2016-2025 (USD Million)
- 5.3. Lymphoscintigraphy
  - 5.3.1. Global Lymphoedema Diagnostics Market By Product2, 2016-2025 (USD Million)
- 5.4. Computed Tomography
  - 5.4.1. Global Lymphoedema Diagnostics Market By Product3, 2016-2025 (USD Million)
- 5.5. Ultrasound Imaging
  - 5.5.1. Global Lymphoedema Diagnostics Market By Product4, 2016-2025 (USD Million)
- 5.6. Bioimpedance Analysis
  - 5.6.1. Global Lymphoedema Diagnostics Market By Bioimpedance Analysis, 2016-2025 (USD Million)
- 5.7. Near-infrared Fluorescence Imaging
  - 5.7.1. Global Lymphoedema Diagnostics Market By Near-infrared Fluorescence Imaging, 2016-2025 (USD Million)
- 5.8. ICG Lymphography
  - 5.8.1. Global Lymphoedema Diagnostics Market By ICG Lymphography, 2016-2025 (USD Million)
- 5.9. Fluorescein Sodium Microlymphangiography
  - 5.9.1. Global Lymphoedema Diagnostics Market By Fluorescein Sodium Microlymphangiography, 2016-2025 (USD Million)
Chapter 6. Global Lymphoedema Diagnostics Market -Disease type Analysis
- 6.1. Global Lymphoedema Diagnostics Market overview: By Disease type
  - 6.1.1. Global Lymphoedema Diagnostics Market share, By Disease type, 2018 and 2025
- 6.2. Cancer
  - 6.2.1. Global Lymphoedema Diagnostics Market By Cancer, 2016-2025 (USD Million)
- 6.3. Cardiovascular Disease
  - 6.3.1. Global Lymphoedema Diagnostics Market By Cardiovascular Disease, 2016-2025 (USD Million)
- 6.4. Inflammatory Diseases
  - 6.4.1. Global Lymphoedema Diagnostics Market By Inflammatory Diseases, 2016-2025 (USD Million)
- 6.5. Others
  - 6.5.1. Global Lymphoedema Diagnostics Market By Other Disease types, 2016-2025 (USD Million)
Chapter 7. Global Lymphoedema Diagnostics Market -Distribution Channel Analysis
- 7.1. Global Lymphoedema Diagnostics Market overview: By Distribution Channel
  - 7.1.1. Global Lymphoedema Diagnostics Marketshare, By Distribution Channel, 2018 and 2025
- 7.2. Hospital Pharmacies
  - 7.2.1. Global Lymphoedema Diagnostics Market By Hospital Pharmacies, 2016-2025 (USD Million)
- 7.3. Retail Pharmacies
  - 7.3.1. Global Lymphoedema Diagnostics Market By Retail Pharmacies, 2016-2025 (USD Million)
- 7.4. Others
  - 7.4.1. Global Lymphoedema Diagnostics Market By others, 2016-2025 (USD Million)
Chapter 8. Global Lymphoedema Diagnostics Market - Regional Analysis
- 8.1. Global Lymphoedema Diagnostics Market overview: By Region
  - 8.1.1. Global Lymphoedema Diagnostics Marketshare, By Region, 2018 and 2025
- 8.2. North America
  - 8.2.1. North America Lymphoedema Diagnostics Market, 2016-2025 (USD Million)
  - 8.2.2. North America Lymphoedema Diagnostics Market revenue, By Product,2016-2025 (USD Million)
  - 8.2.3. North America Lymphoedema Diagnostics Marketrevenue, By Disease type, 2016-2025 (USD Million)
  - 8.2.4. North America Lymphoedema Diagnostics Market revenue, By Distribution Channel, 2016-2025 (USD Million)
  - 8.2.5. The U.S.
    - 8.2.5.1. The U.S.Lymphoedema Diagnostics Market revenue, By Product,2016-2025 (USD Million)
    - 8.2.5.2. The U.S.Lymphoedema Diagnostics Market revenue, By Disease type, 2016-2025 (USD Million)
    - 8.2.5.3. The U.S.Lymphoedema Diagnostics Market revenue, By Distribution Channel, 2016-2025 (USD Million)
  - 8.2.6. Rest of North America
    - 8.2.6.1. Rest of North America Lymphoedema Diagnostics Market revenue, By Product,2016-2025 (USD Million)
    - 8.2.6.2. Rest of North America Lymphoedema Diagnostics Market revenue, By Disease type, 2016-2025 (USD Million)
    - 8.2.6.3. Rest of North America Lymphoedema Diagnostics Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.3. Europe
  - 8.3.1. EuropeLymphoedema Diagnostics Market2016-2025 (USD Million)
  - 8.3.2. Europe Lymphoedema Diagnostics Market revenue, By Product,2016-2025 (USD Million)
  - 8.3.3. Europe Lymphoedema Diagnostics Market revenue, By Disease type, 2016-2025 (USD Million)
  - 8.3.4. Europe Lymphoedema Diagnostics Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
  - 8.3.5. UK
    - 8.3.5.1. U.K.Lymphoedema Diagnostics Market revenue, By Product,2016-2025 (USD Million)
    - 8.3.5.2. U.K.Lymphoedema Diagnostics Market revenue, By Disease type, 2016-2025 (USD Million)
    - 8.3.5.3. U.K. Lymphoedema Diagnostics Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
  - 8.3.6. France
    - 8.3.6.1. France Lymphoedema Diagnostics Market revenue, By Product,2016-2025 (USD Million)
    - 8.3.6.2. France Lymphoedema Diagnostics Market revenue, By Disease type, 2016-2025 (USD Million)
    - 8.3.6.3. France Lymphoedema Diagnostics Market revenue, By Distribution Channel, 2016-2025 (USD Million)
  - 8.3.7. Germany
    - 8.3.7.1. Germany Lymphoedema Diagnostics Market revenue, By Product,2016-2025 (USD Million)
    - 8.3.7.2. Germany Lymphoedema Diagnostics Marketrevenue, By Disease type, 2016-2025 (USD Million)
    - 8.3.7.3. Germany Lymphoedema Diagnostics Market revenue, By Distribution Channel, 2016-2025 (USD Million)
  - 8.3.8. Rest of Europe
    - 8.3.8.1. Rest of EuropeLymphoedema Diagnostics Market revenue, By Product,2016-2025 (USD Million)
    - 8.3.8.2. Rest of EuropeLymphoedema Diagnostics Marketrevenue, By Disease type, 2016-2025 (USD Million)
    - 8.3.8.3. Rest of Europe Lymphoedema Diagnostics Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.4. Asia Pacific
  - 8.4.1. Asia Pacific Lymphoedema Diagnostics Market, 2016-2025 (USD Million)
  - 8.4.2. Asia Pacific Lymphoedema Diagnostics Marketrevenue, By Product,2016-2025 (USD Million)
  - 8.4.3. Asia Pacific Lymphoedema Diagnostics Market revenue, By Disease type, 2016-2025 (USD Million)
  - 8.4.4. Asia Pacific Lymphoedema Diagnostics Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
  - 8.4.5. China
    - 8.4.5.1. China Lymphoedema Diagnostics Market revenue, By Product,2016-2025 (USD Million)
    - 8.4.5.2. China Lymphoedema Diagnostics Market revenue, By Disease type, 2016-2025 (USD Million)
    - 8.4.5.3. China Lymphoedema Diagnostics Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
  - 8.4.6. Japan
    - 8.4.6.1. Japan Lymphoedema Diagnostics Market revenue, By Product,2016-2025 (USD Million)
    - 8.4.6.2. Japan Lymphoedema Diagnostics Marketrevenue, By Disease type, 2016-2025 (USD Million)
    - 8.4.6.3. Japan Lymphoedema Diagnostics Market revenue, By Distribution Channel, 2016-2025 (USD Million)
  - 8.4.7. India
    - 8.4.7.1. India Lymphoedema Diagnostics Market revenue, By Product,2016-2025 (USD Million)
    - 8.4.7.2. India Lymphoedema Diagnostics Marketrevenue, By Disease type, 2016-2025 (USD Million)
    - 8.4.7.3. India Lymphoedema Diagnostics Market revenue, By Distribution Channel, 2016-2025 (USD Million)
  - 8.4.8. Rest of Asia Pacific
    - 8.4.8.1. Rest of Asia Pacific Lymphoedema Diagnostics Marketrevenue, By Product,2016-2025 (USD Million)
    - 8.4.8.2. Rest of Asia Pacific Lymphoedema Diagnostics Market revenue, By Disease type, 2016-2025 (USD Million)
    - 8.4.8.3. Rest of Asia Pacific Lymphoedema Diagnostics Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.5. Latin America
  - 8.5.1. Latin America Lymphoedema Diagnostics Market, 2016-2025 (USD Million)
  - 8.5.2. Latin America Lymphoedema Diagnostics Market revenue, By Product,2016-2025 (USD Million)
  - 8.5.3. Latin America Lymphoedema Diagnostics Market revenue, By Disease type, 2016-2025 (USD Million)
  - 8.5.4. Latin America Lymphoedema Diagnostics Market revenue, By Distribution Channel, 2016-2025 (USD Million)
  - 8.5.5. Brazil
    - 8.5.5.1. Brazil Lymphoedema Diagnostics Marketrevenue, By Product,2016-2025 (USD Million)
    - 8.5.5.2. Brazil Lymphoedema Diagnostics Market revenue, By Disease type, 2016-2025 (USD Million)
    - 8.5.5.3. Brazil Lymphoedema Diagnostics Market revenue, By Distribution Channel, 2016-2025 (USD Million)
  - 8.5.6. Rest of LatinAmerica
    - 8.5.6.1. Rest of LatinAmerica Lymphoedema Diagnostics Market revenue, By Product,2016-2025 (USD Million)
    - 8.5.6.2. Rest of LatinAmerica Lymphoedema Diagnostics Market revenue, By Disease type, 2016-2025 (USD Million)
    - 8.5.6.3. Rest of Latin America Lymphoedema Diagnostics Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.6. The Middle East and Africa
  - 8.6.1. The Middle East and Africa Lymphoedema Diagnostics Market, 2016-2025 (USD Million)
  - 8.6.2. The Middle East and Africa Lymphoedema Diagnostics Marketrevenue, By Product,2016-2025 (USD Million)
  - 8.6.3. The Middle East and Africa Lymphoedema Diagnostics Market revenue, By Disease type, 2016-2025 (USD Million)
  - 8.6.4. The Middle East and Africa Lymphoedema Diagnostics Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
Chapter 9. Company Profiles
- 9.1. Bausch Health Companies
  - 9.1.1. Overview
  - 9.1.2. Financials
  - 9.1.3. Product Portfolio
  - 9.1.4. Business Strategy
  - 9.1.5. Recent Developments
- 9.2. Galderma S.A
  - 9.2.1. Overview
  - 9.2.2. Financials
  - 9.2.3. Product Portfolio
  - 9.2.4. Business Strategy
  - 9.2.5. Recent Developments
- 9.3. Celtic Pharma
  - 9.3.1. Overview
  - 9.3.2. Financials
  - 9.3.3. Product Portfolio
  - 9.3.4. Business Strategy
  - 9.3.5. Recent Developments
- 9.4. Anacor pharmaceuticals, Inc.
  - 9.4.1. Overview
  - 9.4.2. Financials
  - 9.4.3. Product Portfolio
  - 9.4.4. Business Strategy
  - 9.4.5. Recent Developments
- 9.5. Johnson & Johnson
  - 9.5.1. Overview
  - 9.5.2. Financials
  - 9.5.3. Product Portfolio
  - 9.5.4. Business Strategy
  - 9.5.5. Recent Development
- 9.6. Novartis AG, Pfizer Inc.
  - 9.6.1. Overview
  - 9.6.2. Financials
  - 9.6.3. Product Portfolio
  - 9.6.4. Business Strategy
  - 9.6.5. Recent Development
- 9.7. GlaxoSmithKline
  - 9.7.1. Overview
  - 9.7.2. Financials
  - 9.7.3. Product Portfolio
  - 9.7.4. Business Strategy
  - 9.7.5. Recent Development
- 9.8. Topica Pharmaceuticals, Inc.
  - 9.8.1. Overview
  - 9.8.2. Financials
  - 9.8.3. Product Portfolio
  - 9.8.4. Business Strategy
  - 9.8.5. Recent Development
- 9.9. Moberg Pharma AB
  - 9.9.1. Overview
  - 9.9.2. Financials
  - 9.9.3. Product Portfolio
  - 9.9.4. Business Strategy
  - 9.9.5. Recent Development
- 9.10. Bayer AG
  - 9.10.1. Overview
  - 9.10.2. Financials
  - 9.10.3. Product Portfolio
  - 9.10.4. Business Strategy
  - 9.10.5. Recent Development

Methodology

FrequentlyAsked Questions

What are Lymphoedema Diagnostics?

Lymphoedema diagnostics involve a range of techniques to accurately identify and assess lymphoedema, a condition characterized by the accumulation of lymph fluid and swelling in tissues, typically affecting the arms or legs.

What will be the value of the Lymphoedema Diagnostics Market during 2024-2032?

According to study, the Lymphoedema Diagnostics Market size was worth around USD 32.68 million in 2023 and is predicted to grow to around USD 62.66 million by 2032.

What will be the CAGR value of the Lymphoedema Diagnostics Market during 2024-2032?

The CAGR value of Lymphoedema Diagnostics Market is expected to be around 7.5% during 2024-2032.

Which region will contribute notably towards the Lymphoedema Diagnostics Market value?

Asia Pacific has been leading the Lymphoedema Diagnostics Market and is anticipated to continue on the dominant position in the years to come.

Which are the major players leveraging the Lymphoedema Diagnostics Market growth?

The Lymphoedema Diagnostics Market is led by players like Bausch Health Companies, Galderma S.A., Celtic Pharma, Anacor pharmaceuticals Inc., Johnson & Johnson, Novartis AG, Pfizer Inc., GlaxoSmithKline, Topica Pharmaceuticals Inc., Moberg Pharma AB, Bayer AG, Dr. Reddy’s Laboratories Ltd, Allergen Inc., Cipla Ltd, Medimetriks Pharmaceuticals Inc., Sanofi S.A., NovaBiotics Inc., and Merz Pharma. amongst others.